Medicare to spend nearly $400 million on RCD project, it says. While recently released documents on the Review Choice Demonstration for Home Health Services are shedding some lights on a … Continue Reading →
Hospice nursing supervisor admits to hastening patients’ death with overmedication. Two hospice fraud and abuse cases have widely publicized developments that may make hospices’ missions harder. Case #1: Trustbridge, the … Continue Reading →
Nearly $1.5 billion in recoveries keeps the OIG on task. If you’re waiting for federal fraud-fighting efforts to lighten up, you’ll be waiting a long time. So indicates the latest HHS … Continue Reading →
Even agencies that qualify for exemption will be subject to 5% ‘spot check.’ One of the most pressing questions for the home health agencies scheduled to undergo the relaunched Pre-Claim … Continue Reading →
Watchdog agency profiles Texas, Florida cases. The feds continue to paint home care with a broad fraud brush, as evidenced by the OIG’s latest Semiannual Report to Congress. “Home- and community-based … Continue Reading →
Only slight improvement shown by claims data. Medicare’s hoped-for solution for boosting care levels in the last days of life has yet to materialize, the 2019 proposed rule for hospice … Continue Reading →
You should be paying for insulin, beta blockers, and more, CMS instructs. Data revealed in the latest hospice payment proposed rule may indicate more medication payment crackdowns for hospices — … Continue Reading →
LOS ticks upward. You have only a matter of days left to give Medicare your two cents on its proposed rule for hospice payment for next year. Consider these 2017 … Continue Reading →
Learn from original PCR run, trade group tells Medicare officials. Unlike with the original Pre-Claim Review demonstration, home health agencies are hoping to head off the medical review project before … Continue Reading →
GAO wants Pre-Claim Review to resume. Medicare is revealing more details about its resurrected Pre-Claim Review demonstration project, which it’s now calling the “Review Choice Demonstration.” But many specifics remain … Continue Reading →
